ZEPP vs FOSL

For growth investors, Fossil Group, Inc.

(FOSL) is the stronger pick with -12. 3% revenue growth year-over-year, versus -46. 6% for Zepp Health Corporation (ZEPP). Analysts rate Fossil Group, Inc. (FOSL) a "Hold" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Zepp Health Corporation (ZEPP) delivered a total return of -60.

7%, compared to -63. 3% for Fossil Group, Inc. (FOSL). Over 10 years, the gap is even starker: ZEPP returned -66. 6% versus FOSL's -88. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Zepp Health Corporation (ZEPP) is the lower-risk stock at 1.

63β versus Fossil Group, Inc. 's 2. 46β — meaning FOSL is approximately 51% more volatile than ZEPP relative to the S&P 500. On balance sheet safety, Zepp Health Corporation (ZEPP) carries a lower debt/equity ratio of 72% versus 3% for Fossil Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Fossil Group, Inc.

(FOSL) is pulling ahead at -12. 3% versus -46. 6% for Zepp Health Corporation (ZEPP). On earnings-per-share growth, the picture is similar: Fossil Group, Inc. grew EPS 25. 3% year-over-year, compared to -1642. 9% for Zepp Health Corporation. Over a 3-year CAGR, FOSL leads at -15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Fossil Group, Inc.

(FOSL) is the more profitable company, earning -7. 8% net margin versus -41. 6% for Zepp Health Corporation — meaning it keeps -7. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FOSL leads at 2. 3% versus -25. 9% for ZEPP. At the gross margin level — before operating expenses — FOSL leads at 56. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for FOSL: 55.

9% to $7. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Zepp Health Corporation (ZEPP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.

Fossil Group, Inc. (FOSL) carries a higher beta of 2. 46 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ZEPP: -66. 6%, FOSL: -88. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ZEPP (Technology) and FOSL (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.